Search
Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the 2022 Rowan University Cannabis Forum: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session will cover the implications of cannabis legislation on businesses and...
Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the Rowan University Cannabis Forum 2022: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session is entitled "Implications of Cannabis Legislation on Businesses...
Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will speak during the 2022 Tobacco/OTP + CBD Forum in Orlando, FL.
MAKING SENSE OF PRES. BIDEN’S CANNABIS REFORM STATEMENT – FDA’S ROLE IN SCHEDULING EVALUATION Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will discuss President Biden’s recent cannabis reform announcement, its implications for various stakeholders, and FDA’s role in evaluating how...
INTO THE RABBIT HOLE OF PSYCHEDELICS: EXPLORING MDMA, PSILOCYBIN, LSD, AYAHUASCA, DMT, IBOGAINE, KETAMINE, AND OTHER PSYCHEDELICS. Jonathan Havens, Co-Chair of the Firm's Cannabis Practice, will be speaking at the Psychedelic Medicine Conference/CBD Expo. Jonathan's panel will dive down the rabbit...
Jonathan Havens, Co-Chair of Saul Ewing's Cannabis Law Practice, will speak at The Cannabis and Psychedelics Investment Summit in London on September 20, 2022. Jonathan will be joining a panel entitled "A Legal Overview: The Future of Cannabis and Psychedelic Policy."
Partner Zachary Kobrin authored an article in Cannabis Business Times that outlined 11 considerations for cannabis operators when applying for a license. The article explains that without millions of dollars to acquire a cannabis license from an existing holder, businesses are required to submit a...
EXPLORING THE REGULATION, LITIGATION AND ENFORCEMENT OF MARIJUANA Jonathan Havens, co-chair of the Firm's Cannabis Law Practice, will speak at ACI’s Controlled Substances – Regulation, Litigation, and Enforcement Summit in Washington, DC on July 12th as a panelist during the session on “Exploring...
Cannabis Law Partner Zachary Kobrin published an article for the Cannabis Industry Journal on how the cannabis industry can benefit from the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act which was recently introduced in Congress. The Act creates greater access to capital...